Moors & Cabot, Inc. Scopus Bio Pharma Inc. Transaction History

Moors & Cabot, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 08, 2022	SELL	$0.36 - $0.74 $5,220 - $10,730	-14,500 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.6 - $1.7 $8,700 - $24,650	14,500 New	14,500 $10,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.